Literature DB >> 17186247

Significance of mesorectal volume in staging of rectal cancer with magnetic resonance imaging and the assessment of involvement of the mesorectal fascia.

Michael R Torkzad1, Karl A Hansson, Johan Lindholm, Anna Martling, Lennart Blomqvist.   

Abstract

The aim was to study the influence of mesorectal volume, as estimated by magnetic resonance imaging (MRI), that is to be removed during total mesorectal excision (TME), on the accuracy of the first preoperative MRI of rectal cancer compared to histopathology, and its correlation to locoregional prognostic factors. A total of 267 rectal cancer patients from a multinational study (MERCURY or MRI equivalence study) had their mesorectal volume retrospectively estimated by researchers without knowledge of the assessments made by the radiologist or the pathologist. The evaluations made by the pathologist and the radiologist were then compared, including T- and N-staging, assessment of extent of extramural tumor invasion (the largest portion of the tumor beyond the muscularis propria or EMI) and distance to mesorectal fascia; the discrepancies in the results were correlated to the mesorectal volume. T- or N-staging accuracy by MRI and the difference between the EMI as measured by the pathologist and the radiologist were not dependent on individual mesorectal volume. There was no correlation between assessment of involvement of mesorectal fascia or local neighboring organs by MRI and histopathology with mesorectal volume. Mesorectal volume does not affect locoregional prognostic factors or the accuracy of local staging of rectal cancer.

Entities:  

Mesh:

Year:  2006        PMID: 17186247     DOI: 10.1007/s00330-006-0521-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  24 in total

1.  Radiological findings do not support lateral residual tumour as a major cause of local recurrence of rectal cancer.

Authors:  E Syk; M R Torkzad; L Blomqvist; O Ljungqvist; B Glimelius
Journal:  Br J Surg       Date:  2006-01       Impact factor: 6.939

2.  The pelvis after surgery and radio-chemotherapy for rectal cancer studied with Gd-DTPA-enhanced fast dynamic MR imaging.

Authors:  L Blomqvist; P Fransson; T Hindmarsh
Journal:  Eur Radiol       Date:  1998       Impact factor: 5.315

3.  Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging?

Authors:  T Denecke; B Rau; K-T Hoffmann; B Hildebrandt; J Ruf; M Gutberlet; M Hünerbein; R Felix; P Wust; H Amthauer
Journal:  Eur Radiol       Date:  2005-04-02       Impact factor: 5.315

4.  The mesorectum: morphometric assessment with magnetic resonance imaging.

Authors:  Michael R Torkzad; Lennart Blomqvist
Journal:  Eur Radiol       Date:  2005-01-27       Impact factor: 5.315

5.  Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project.

Authors:  A L Martling; T Holm; L E Rutqvist; B J Moran; R J Heald; B Cedemark
Journal:  Lancet       Date:  2000-07-08       Impact factor: 79.321

6.  Retrospective measurement of different size parameters of non-radiated rectal cancer on MR images and pathology slides and their comparison.

Authors:  Michael Torkzad; Johan Lindholm; Anna Martling; Lennart Blomqvist
Journal:  Eur Radiol       Date:  2003-05-10       Impact factor: 5.315

7.  Prognostic factors of rectum carcinoma--experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma.

Authors:  P Hermanek; H Wiebelt; D Staimmer; S Riedl
Journal:  Tumori       Date:  1995 May-Jun       Impact factor: 2.098

8.  Mesorectal excision for rectal cancer.

Authors:  R J Aitken
Journal:  Br J Surg       Date:  1996-02       Impact factor: 6.939

Review 9.  Advances in surgical treatment of rectal cancer.

Authors:  E Rullier; C Laurent
Journal:  Minerva Chir       Date:  2003-08       Impact factor: 1.000

10.  The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?

Authors:  R J Heald; E M Husband; R D Ryall
Journal:  Br J Surg       Date:  1982-10       Impact factor: 6.939

View more
  6 in total

1.  Correlation of rectal tumor volumes with oncological outcomes for low rectal cancers: does tumor size matter?

Authors:  Muhammad Tayyab; Abdul Razack; Abhiram Sharma; James Gunn; John E Hartley
Journal:  Surg Today       Date:  2014-11-07       Impact factor: 2.549

2.  Factors related to preoperative assessment of the circumferential resection margin and the extent of mesorectal invasion by magnetic resonance imaging in rectal cancer: a prospective comparison study.

Authors:  Young-Wan Kim; Seung-Whan Cha; Juyon Pyo; Nam-Kyu Kim; Byung-Soh Min; Myeong-Jin Kim; Hoguen Kim
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

3.  Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review.

Authors:  Michael R Torkzad; Lars Påhlman; Bengt Glimelius
Journal:  Insights Imaging       Date:  2010-08-15

Review 4.  Detection of recurrent rectal cancer with CT, MRI and PET/CT.

Authors:  O Schaefer; M Langer
Journal:  Eur Radiol       Date:  2007-04-03       Impact factor: 7.034

Review 5.  Magnetic resonance imaging and endorectal ultrasound for diagnosis of rectal lesions.

Authors:  Franciszek Burdan; Iwona Sudol-Szopinska; Elzbieta Staroslawska; Malgorzata Kolodziejczak; Robert Klepacz; Agnieszka Mocarska; Marek Caban; Iwonna Zelazowska-Cieslinska; Justyna Szumilo
Journal:  Eur J Med Res       Date:  2015-01-14       Impact factor: 2.175

6.  Assessment of T and N staging with MRI3T in lower and middle rectal cancer and impact on clinical strategy.

Authors:  Liping Xu; Zhaoyue Zhang; Qin Qin; Chi Zhang; Xinchen Sun
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.